| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000037101 |
| Receipt No. | R000042276 |
| Scientific Title | Prospective study on evaluation of amyloid accumulation in patients suspected of both cerebral amyloid angiopathy and isolated cortical venous thrombosis using Amyloid positron emission tomography |
| Date of disclosure of the study information | 2019/06/20 |
| Last modified on | 2020/07/22 (Ver. 5) |
| Basic information | ||
| Public title | Prospective study on evaluation of amyloid accumulation in patients suspected of both cerebral amyloid angiopathy and isolated cortical venous thrombosis using Amyloid positron emission tomography | |
| Acronym | ALPS-VACANCES | |
| Scientific Title | Prospective study on evaluation of amyloid accumulation in patients suspected of both cerebral amyloid angiopathy and isolated cortical venous thrombosis using Amyloid positron emission tomography | |
| Scientific Title:Acronym | ALPS-VACANCES | |
| Region |
|
|
| Condition | ||||
| Condition | cerebral amyloid angiopathy
isolated cortical venous thrombosis |
|||
| Classification by specialty |
|
|||
| Classification by malignancy | Others | |||
| Genomic information | NO | |||
| Objectives | |
| Narrative objectives1 | There are patients who have low signal lesion with T2* weighted image along on the surface of brain which is associated with local neurological symptoms without cortical multiple microhemorrhages typical for CAA. Such cases could be diagnosed as both CAA and isolated cerebral cortical venous thrombosis (ICVT). The purpose of this study is to evaluate the differences in the pathogenesis of ICVT and CAA, focusing on the degree of cerebral amyloid deposition using amyloid PET. |
| Basic objectives2 | Others |
| Basic objectives -Others | Cerebral amyloid deposition using amyloid PET |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Amyloid beta protein deposition with [11C] PiB PET. |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) T2* weighted image demonstrates linear low intensities along surface of the brain.
2) Neurological symptoms (including transient) correlate with the cortical linear lesions in T2* weighted image. 3) Two or more physicians diagnose that multiple cortical micro bleeds in the cerebrum or cerebellum are not conspicuous on T2* weighted image. 4) The score of Mini Mental State Examination is not matter. 5) Age and gender do not matter. 6) The written informed consent is obtained from the patient or representative. |
|||
| Key exclusion criteria | 1. Highly suspected with CAA
2. Diagnosed as Alzheimer's disease 3. Contraindication for MRI (pacemaker, brain clip etc) 4. Inappropriate cases to participate in this study judged by the physicians. |
|||
| Target sample size | 50 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Kohnan Hospital | ||||||
| Division name | Department of Stroke Neurology | ||||||
| Zip code | 9828523 | ||||||
| Address | Nagamachiminami 4-20-1, Taihakuku, Sendai, Miyagi, Japan | ||||||
| TEL | 022-248-2131 | ||||||
| rmkitabash@gmail.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Kohnan Hospital | ||||||
| Division name | Department of Stroke Neurology | ||||||
| Zip code | 9828523 | ||||||
| Address | Nagamachiminami 4-20-1, Taihakuku, Sendai, Miyagi, Japan | ||||||
| TEL | 0222482131 | ||||||
| Homepage URL | |||||||
| juri3@kohnan-sendai.or.jp | |||||||
| Sponsor | |
| Institute | Kohnan Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Kohnan Hospital Ethics Committee |
| Address | Nagamachi-minami 4-20-1 |
| Tel | +81222482131 |
| m-fuji@kohnan-sendai.or.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 4 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | There are patients with linear low signal lesions along the brain surface on MRI T2* weighted image accompanied with local neurologic symptoms associated with them. In these patients, cerebral or cerebellar cortical microbleeds which are typical in patients with cerebral amyloid angiopathy (CAA) is inconspicuous. Such cases can be ether CAA with amyloid spell or isolated cortical venous thrombosis (ICVT). In this study, amyloid PET imaging (amyloid PET) would be performed on such cases to evaluate the status of amyloid beta protein deposition. The purpose of this study is to address the differences in the pathogenesis of ICVT and CAA, focusing on the degree of cerebral amyloid deposition. Based on the anatomical information of MRI image, the SUVR (SUV value on amyloid PET of cerebral cortex is divided by the one of cerebellum) was calculated. In addition, we would obtain control data from patients with Alzheimer's disease and healthy elderly people used in previous research. SUVR were compared among three groups (20 patients with Alzheimer's disease, 20 healthy controls and 10 patients in this study). |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042276 |